Literature DB >> 11510469

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance.

R Fonseca, M M Oken, P R Greipp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11510469     DOI： 10.1182/blood.v98.4.1271

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  14 in total

1.  Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma.

Authors:  Miki Kiyota; Tsutomu Kobayashi; Shinichi Fuchida; Mio Yamamoto-Sugitani; Muneo Ohshiro; Yuji Shimura; Shinsuke Mizutani; Hisao Nagoshi; Nana Sasaki; Ryuko Nakayama; Yoshiaki Chinen; Natsumi Sakamoto; Hitoji Uchiyama; Yosuke Matsumoto; Shigeo Horiike; Chihiro Shimazaki; Junya Kuroda; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2012-03-17       Impact factor: 2.490

2.  Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.

Authors:  A K Stewart; H Chang; S Trudel; K C Anderson; P Richardson; M Alsina; D Reece; S Young; A Sable-Hunt; Z Li; J Keats; S Van Wier; G Ahmann; T Price-Troska; K Giusti; P L Bergsagel; M Chesi; R Fonseca
Journal:  Leukemia       Date:  2007-06-14       Impact factor: 11.528

3.  Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.

Authors:  Alvin S T Lim; Sathish Krishnan; Tse Hui Lim; Karen See; Yit Jun Ng; Yu Min Tan; Natasha Choo; Lai Ching Lau; Sim Leng Tien; Jun Ma; Daryl Tan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-09-04       Impact factor: 0.900

4.  Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.

Authors:  Gordon W Dewald; Terry Therneau; Dirk Larson; You Kyoung Lee; Stephanie Fink; Stephanie Smoley; Sarah Paternoster; Adewale Adeyinka; Rhett Ketterling; Daniel L Van Dyke; Rafael Fonseca; Robert Kyle
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

5.  Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.

Authors:  Angela Baker; Esteban Braggio; Susanna Jacobus; Sungwon Jung; Dirk Larson; Terry Therneau; Angela Dispenzieri; Scott A Van Wier; Gregory Ahmann; Joan Levy; Louise Perkins; Seungchan Kim; Kimberly Henderson; David Vesole; S Vincent Rajkumar; Diane F Jelinek; John Carpten; Rafael Fonseca
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

Review 6.  Genetic events in the pathogenesis of multiple myeloma.

Authors:  W J Chng; O Glebov; P L Bergsagel; W M Kuehl
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

7.  Genetic aberrations and survival in plasma cell leukemia.

Authors:  R E Tiedemann; N Gonzalez-Paz; R A Kyle; R Santana-Davila; T Price-Troska; S A Van Wier; W J Chng; R P Ketterling; M A Gertz; K Henderson; P R Greipp; A Dispenzieri; M Q Lacy; S V Rajkumar; P L Bergsagel; A K Stewart; R Fonseca
Journal:  Leukemia       Date:  2008-01-24       Impact factor: 11.528

Review 8.  Molecular aspects of multiple myeloma.

Authors:  G Pratt
Journal:  Mol Pathol       Date:  2002-10

Review 9.  International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Authors:  R Fonseca; P L Bergsagel; J Drach; J Shaughnessy; N Gutierrez; A K Stewart; G Morgan; B Van Ness; M Chesi; S Minvielle; A Neri; B Barlogie; W M Kuehl; P Liebisch; F Davies; S Chen-Kiang; B G M Durie; R Carrasco; Orhan Sezer; Tony Reiman; Linda Pilarski; H Avet-Loiseau
Journal:  Leukemia       Date:  2009-10-01       Impact factor: 11.528

10.  The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies.

Authors:  A Kalff; A Spencer
Journal:  Blood Cancer J       Date:  2012-09-07       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.